In addition to tumor cells, CXCR4 is expressed by several other cell types, including macrophages and endothelial cells, and the CXCL12—CXCR4 pathway is associated with tumor progression, metastasis, and angiogenesis (reviewed in [39]), also providing an attractive target for melanoma therapy. The gene discussed is CXCL12; the disease is melanoma.